BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 12549846)

  • 21. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae.
    Ghorpade A
    Int J Dermatol; 2014 Feb; 53(2):221-3. PubMed ID: 24319988
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
    Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
    Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molluscum contagiosum-like lesions in lepromatous leprosy.
    Mukhopadhyay AK
    Indian J Lepr; 2005; 77(2):156-61. PubMed ID: 16044815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
    Desikan P; Desikan KV
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bullous erythema nodosum leprosum: a case report from Nepal.
    Rijal A; Agrawal S; Agarwalla A; Lakhey M
    Lepr Rev; 2004 Jun; 75(2):177-80. PubMed ID: 15282970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
    Cellona RV; Fajardo TT; Kim DI; Hah YM; Ramasoota T; Sampattavanich S; Carrillo MP; Abalos RM; dela Cruz EC; Ito T
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
    Kar HK; Raina A; Sharma PK; Bhardwaj M
    Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
    Benard G; Sakai-Valente NY; Bianconcini Trindade MA
    Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ref: Role of azathioprine in preventing recurrence of ENL in a patient--article by K K Verma et al. Lepr Rev (2006) 77: 225-229.
    Sunkad M
    Lepr Rev; 2007 Jun; 78(2):170. PubMed ID: 17824492
    [No Abstract]   [Full Text] [Related]  

  • 36. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
    Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current guidelines for leprosy treatment].
    Flageul B
    Bull Soc Pathol Exot; 2003 Jan; 96(5):357-61. PubMed ID: 15015839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.